Sagimet Biosciences (SGMT) Interest Coverage Ratio (2022 - 2026)
Sagimet Biosciences' (SGMT) quarterly Interest Coverage Ratio came in at 5.88 in Q1 2026, up 99.23% year-on-year from 2.95 in Q1 2025, and down 107.4% quarter-over-quarter from 2.83 in Q4 2025.
Sagimet Biosciences (SGMT) Interest Coverage Ratio (2022 - 2026) Analysis & Trends
Sagimet Biosciences' Interest Coverage Ratio history runs 5 years deep, the most recent figure standing at 5.88 for Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 99.23% year-over-year to 5.88 in Q1 2026; TTM through Mar 2026 was 24.45, a 99.03% increase from a year earlier, with the FY2025 full-year figure at 14.97, down 1725.74% from the prior year.
- Interest Coverage Ratio declined to 5.88 in Q1 2026 per SGMT's latest filing, from 2.83 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.17 in Q4 2023 and bottomed at 1096.0 in Q1 2024.
- The 5-year median for Interest Coverage Ratio is 1.94 (2025), against an average of 172.59.
- Across the five-year window, Interest Coverage Ratio sank 59122.35% in 2024 and surged 99.44% in 2025, its largest moves.
- Year by year, Interest Coverage Ratio stood at 1.85 in 2022, then soared by 90.71% to 0.17 in 2023, then slumped by 59.57% to 0.27 in 2024, then plunged by 933.96% to 2.83 in 2025, then slumped by 107.4% to 5.88 in 2026.
- Per Business Quant, the three latest SGMT Interest Coverage Ratio figures stand at 5.88 (Q1 2026), 2.83 (Q4 2025), and 2.03 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Sagimet Biosciences | 228.24 Mn | 228.24 Mn | - | -5.88 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.88 |
| Dec 31, 2025 | -2.83 |
| Sep 30, 2025 | -2.03 |
| Jun 30, 2025 | -1.11 |
| Mar 31, 2025 | -764.04 |
| Dec 31, 2024 | -0.27 |
| Jun 30, 2024 | -196.09 |
| Mar 31, 2024 | -1,096.00 |
| Dec 31, 2023 | -0.17 |
| Sep 30, 2023 | -0.42 |
| Jun 30, 2023 | -0.33 |
| Dec 31, 2022 | -1.85 |